Effects of specific interleukin-1β-converting enzyme inhibitor on ischemic acute renal failure in murine models

Acta Pharmacologica Sinica

Volumn 26, Issue 11, 2005, Pages 1345-1351

  Liu, Hua Feng ^a   Liang, Dong ^a   Wang, Li Ming ^a   Zhou, Nan ^a   Yao, Cui Wei ^a   Hong, Tao ^a   Tang, De Shen ^a   Chen, Xiao Wen ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Caspase 1; Interferon type II; Interleukin 1; Interleukin 1 converting enzyme inhibitor; Interleukin 18; Ischemia; Kidney failure

Indexed keywords

ACETYLTYROSYLVALYLALANYLASPARTYLCYSTEINYLMETHIONYLLYSINE; CREATININE; GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; MESSENGER RNA; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REPRESSION; EXPERIMENTAL MODEL; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; KIDNEY FUNCTION TEST; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE NECROSIS; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TIME SERIES ANALYSIS; TRANSCRIPTION REGULATION; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; AMINO ACID CHLOROMETHYL KETONES; ANIMALS; BLOOD UREA NITROGEN; CASPASE 1; CREATININE; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-18; KIDNEY; KIDNEY FAILURE, ACUTE; KIDNEY TUBULES; MALE; MICE; PROTECTIVE AGENTS; RNA, MESSENGER; SERPINS; VIRAL PROTEINS;

EID: 27744479845     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00200.x     Document Type: Article

References (23)

1. Carmichael P, Carmichael AR. Acute renal failure in the surgical setting. ANZ J Surg 2003; 73: 144-53.
2. Wiecek A, Nowicki M, Kokot F, Ritz E. Acute failure of the transplanted kidney - pathophysiology, diagnosis and prevention. Ann Transplant 1996; 1: 5-9.
3. Ysebaert DK, De Greef KE, De Beuf A, Van Rompay AR, Vercauteren S, Persy VP, et al. T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 2004; 66: 491-6.
4. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int 2004; 66: 480-5.
5. Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int 2004; 66: 486-91.
6. Burne-Taney MJ, Kofler J, Yokota N, Weisfeldt M, Traystman RJ, Rabb H, et al. Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am J Physiol Renal Physiol 2003; 285: F87-94.
7. Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004; 43: 405-14.
8. Burne MJ, Daniels F, El Ghandour A, Mauiyyedi S, Colvin RB, O'Donnell MP, et al. Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001; 108: 1283-90.
9. Daemen MA, van't Veer C, Wolfs TG, Buurman WA. Ischemia/reperfusion- induced IFN-gamma up-regulation: involvement of IL-12 and IL-18. J Immunol 1999; 162: 5506-10.
10. Kitada H, Suitani A, Yamamoto H, Otomo N, Okabe Y, Inoue S, et al. Attenuation of renal ischemia-reperfusion injury by FR167653 in dogs. Surgery 2002; 131: 654-9.
11. Melnikov VY, Faubel S, Siegmund B, Lucia MS, Ljubanovic D, Edelstein CL, et al. Neutrophil-independent mechanisms of caspase-1 and IL-18-mediated ischemic acute tubular necrosis in mice. J Clin Invest 2002; 110: 1083-91.
12. Dinarello CA. Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann NY Acad Sci 1998; 856: 1-11.
13. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378: 88-91.
14. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984; 74: 1156-64.
15. Denton MD, Chertow GM, Brady HR. 'Renal-dose' dopamine for the treatment of acute renal failure: scientific rationale, experimental studies and clinical trials. Kidney Int 1996; 50: 4-14.
16. Alkhunaizi AM, Schrier RW. Management of acute renal failure: new perspectives. Am J Kidney Dis 1996; 28: 315-28.
17. Mitaka C, Hirata Y, Habuka K, Narumi Y, Yokoyama K, Makita K, et al. Atrial natriuretic peptide infusion improves ischemic renal failure after suprarenal abdominal aortic cross-clamping in dogs. Crit Care Med 2003; 31: 2205-10.
18. Chatterjee PK, Patel NS, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, et al. The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J2 ameliorates ischemic acute renal failure. Cardiovasc Res 2004; 61: 630-43.
19. Tilney NL, Guttmann RD. Effects of initial ischemia/reperfusion injury on the transplant kidney. J Transplant 1997; 64: 945-7.
20. Kaushal GP, Singh AB, Shah SV. Identification of gene family of caspases in rat kidney and altered expression in ischemia-reperfusion injury. Am J Physiol 1998; 274: 587-95.
21. Haq M, Norman J, Saba SR, Ramirez G, Rabb H. Role of IL-1 in renal ischemic reperfusion injury. J Am Soc Nephrol 1998; 9: 614-9.
22. Melnikov VY, Ecder T, Fantuzzi G, Siegmund B, Lucia MS, Dinarello CA, et al. Impaired IL-18 processing protects caspase-1 deficient mice from ischemic acute renal failure. J Clin Invest 2001; 107: 1145-52.
23. Hedtjarn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H, et al. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 2002; 22: 5910-9.